SpringWorks Therapeutics, Inc.(SWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SWTX SpringWorks Therapeutics, Inc.

盘后交易 07-17 16:45:02 EDT

38.90

-3.01

-7.18%

盘后38.90

+0.000.00%

16:20 EDT

最高41.72	最低38.65	成交量101.26万
今开41.12	昨收41.91	日振幅7.33%
总市值28.80亿	流通市值28.21亿	总股本7,404万
成交额3,969万	换手率1.40%	流通股本7,252万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SWTX","market":"US","secType":"STK","nameCN":"SpringWorks Therapeutics, Inc.","latestPrice":38.9,"timestamp":1721246400000,"preClose":41.91,"halted":0,"volume":1012559,"hourTrading":{"tag":"盘后","latestPrice":38.9,"preClose":38.9,"latestTime":"16:20 EDT","volume":83929,"amount":3264837.596426,"timestamp":1721247601875},"delay":0,"floatShares":72520672,"shares":74037864,"eps":-5.138628,"marketStatus":"盘后交易","marketStatusCode":4,"change":-3.01,"latestTime":"07-17 16:45:02 EDT","open":41.12,"high":41.72,"low":38.65,"amount":39687270.25618,"amplitude":0.073252,"askPrice":39.66,"askSize":42,"bidPrice":39,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-5.138628,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721260800000},"adr":0,"listingDate":1568347200000,"adjPreClose":41.91,"postHourTrading":{"tag":"盘后","latestPrice":38.9,"preClose":38.9,"latestTime":"16:20 EDT","volume":83929,"amount":3264837.596426,"timestamp":1721247601875},"volumeRatio":1.408738,"impliedVol":0.806,"impliedVolPercentile":0.5714},"requestUrl":"/m/hq/s/SWTX","defaultTab":"news","newsList":[{"id":"2434896903","title":"Springworks Therapeutics, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434896903","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434896903?lang=zh_cn&edition=full","pubTime":"2024-05-11 03:52","pubTimestamp":1715370771,"startTime":"0","endTime":"0","summary":"北京时间2024年05月11日03时52分，Springworks Therapeutics, Inc.股票出现异动，股价快速下跌5.01%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc 是一家处于临床阶段的生物制药公司，该公司采用精准医疗的方法，获取、开发和商业化改变生命的药物，用于治疗服务不足的罕见病和癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240511035252861ec807&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240511035252861ec807&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SWTX","LENZ"],"gpt_icon":0},{"id":"2434869688","title":"Springworks Therapeutics, Inc.2024财年第一财季实现净利润-87.39百万美元，同比减少19.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434869688","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434869688?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:17","pubTimestamp":1715357835,"startTime":"0","endTime":"0","summary":"3月31日，Springworks Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-87.39百万美元，同比减少19.03%；其中营业收入为21.01百万美元，每股基本收益为-1.18美元。从资产负债表来看，Springworks Therapeutics, Inc.总负债89.39百万美元，其中短期债务981000.00美元，资产负债比为0.08，流动比率为0.07。机构评级：截至2024年3月31日，当前有9家机构对Springworks Therapeutics, Inc.目标价做出预测，其中目标均价为67.92美元，其中最低目标价为58.00美元，最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051100171987516d06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051100171987516d06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SWTX","LENZ"],"gpt_icon":0},{"id":"2426491231","title":"Springworks Therapeutics, Inc.盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426491231","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426491231?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:32","pubTimestamp":1712755934,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时32分，Springworks Therapeutics, Inc.股票出现异动，股价快速下挫5.08%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.25%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc 是一家处于临床阶段的生物制药公司，该公司采用精准医疗的方法，获取、开发和商业化改变生命的药物，用于治疗服务不足的罕见病和癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213215861e4a49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213215861e4a49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SWTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2417200459","title":"美国研究综述-树皮、Fleetcor Technologies、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2417200459","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417200459?lang=zh_cn&edition=full","pubTime":"2024-03-05 14:57","pubTimestamp":1709621845,"startTime":"0","endTime":"0","summary":"    路透社3月5日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Bark、Fleetcor Technologies 和特斯拉。要闻             * Bark Inc   ：杰富瑞将其评级从 \"持有 \"上调至 \"买入\"；将交易价从1.54美元上调至1.9美元。* Fleetcor Technologies Inc   ：贝尔德将其评级上调至 \"跑赢大盘\"。* 特斯拉  ：加拿大皇家银行将目标价从297美元上调至298美元 以下是路透社周二报道的美国公司研究报告摘要。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGX","APLS","CCOI","SWTX","TSLL","APG","AMPH","AKRO","AMRC","GTLB","CQP","LU1839511570.USD","LU0011850046.USD","NTRA","BLD","AKYA","BK4149","LU1496350171.SGD","LU0097036916.USD","CCCC","LU0310799852.SGD","TSLA","SQSP","HIMS","DSP","FLT","IBP","XPOF","PLNT","GWW","BK4099","PRVA","UNH","BK4097","HSIC","LU1670628061.USD","PDCO","NUVL","BLUE","PAY","PNTG","LU1720051017.SGD","BARK","LU1861558580.USD","RNA","PCAR","HGV","SFIX","IE0004445015.USD","COST"],"gpt_icon":0},{"id":"2416964633","title":"Springworks Therapeutics, Inc.2023财年实现净利润-3.25亿美元，同比减少17.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416964633","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416964633?lang=zh_cn&edition=full","pubTime":"2024-03-03 00:18","pubTimestamp":1709396331,"startTime":"0","endTime":"0","summary":"12月31日，Springworks Therapeutics, Inc.公布财报，公告显示公司2023财年净利润为-3.25亿美元，同比减少17.33%；其中营业收入为5.45百万美元，每股基本收益为-5.15美元。从资产负债表来看，Springworks Therapeutics, Inc.总负债99.57百万美元，其中短期债务1.06百万美元，资产负债比为0.08，流动比率为0.07。机构评级：截至2023年12月31日，当前有8家机构对Springworks Therapeutics, Inc.目标价做出预测，其中目标均价为67.53美元，其中最低目标价为58.00美元，最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030300185687dce6f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030300185687dce6f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SWTX"],"gpt_icon":0},{"id":"2416064186","title":"Springworks Therapeutics, Inc.盘中异动 大幅拉升5.14%报51.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416064186","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416064186?lang=zh_cn&edition=full","pubTime":"2024-03-01 22:37","pubTimestamp":1709303871,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日22时37分，Springworks Therapeutics, Inc.股票出现波动，股价快速上涨5.14%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.14%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc是一家处于临床阶段的生物制药公司，采用精准医学的方法，为患有严重罕见疾病和癌症的患者购买、开发并商业化可以改变生命的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012237517a48953f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012237517a48953f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SWTX"],"gpt_icon":0},{"id":"2413761488","title":"SpringWorks Therapeutics Inc   预计每股亏损1.24美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2413761488","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413761488?lang=zh_cn&edition=full","pubTime":"2024-02-23 22:12","pubTimestamp":1708697575,"startTime":"0","endTime":"0","summary":"   * SpringWorks Therapeutics Inc    将于2月26日公布截至2023年12月31日的业绩报告，预计()，季度收入将有所增长。* 根据 LSEG 的数据，5 位分析师的平均预期显示，这家总部位于康涅狄格州斯坦福德的公司预计将实现 60 万美元的营收。* LSEG 分析师对 SpringWorks Therapeutics Inc 的平均预期为每股亏损 1.24 美元。* 华尔街对 SpringWorks Therapeutics Inc 的 12 个月目标价中位数为 60.00 美元，高于其最新收盘价 49.11 美元。2月23日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SWTX"],"gpt_icon":0},{"id":"2404048328","title":"美国研究综述-Burlington Stores、Carrols Restaurant Group、Mastec","url":"https://stock-news.laohu8.com/highlight/detail?id=2404048328","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2404048328?lang=zh_cn&edition=full","pubTime":"2024-01-17 15:02","pubTimestamp":1705474948,"startTime":"0","endTime":"0","summary":"    路透1月17日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括伯灵顿百货公司、Carrols Restaurant Group 和 Mastec。要点             * Ambrx Biopharma Cayman Inc   ：贝雅将其评级下调至中性             * Burlington Stores Inc   ：Piper Sandler将其评级从中性上调至增持              * Carrols Restaurant Group Inc   ：Stephens将其评级从 \"增持 \"下调至 \"等权重\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DUK","LU0708995401.HKD","TAST","LU0689472784.USD","LU0320765489.SGD","DTM","IE00B19Z3B42.SGD","MS","BK4144","RVLV","LU0130102774.USD","LU0642271901.SGD","LU1244550221.USD","CSWC","LU1989772923.USD","SPR","PNC","GS","MTZ","LU0106831901.USD","ZS","LU1878469433.USD","AMAM","BK4576","HWC","LU1064131342.USD","RARE","IDYA","RTX","RENT","LU0971096721.USD","BURL","RKLB","IE00B66KJ199.SGD","OCSL","CHPT","FBK","ORIC","TGI","MSCI","BK4211","TDG","PSN","ALLK","META","SWTX","NOC","BK4516","SNAP","APLS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.springworkstx.com","stockEarnings":[{"period":"1week","weight":0.0943},{"period":"1month","weight":0.0872},{"period":"3month","weight":-0.0499},{"period":"6month","weight":0.061},{"period":"1year","weight":0.404},{"period":"ytd","weight":0.1482}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1285},{"period":"6month","weight":0.1855},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.1884}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"SpringWorks Therapeutics, Inc.于2017年8月在特拉华州成立。该公司是一家临床阶段的生物制药公司，它使用精密医学来为患有严重疾病和癌症的服务不足的患者人群获取，开发和商品化改变生命的药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.056257},{"month":2,"riseRate":1,"avgChangeRate":0.03933},{"month":3,"riseRate":0,"avgChangeRate":-0.099358},{"month":4,"riseRate":0.2,"avgChangeRate":-0.057063},{"month":5,"riseRate":0.6,"avgChangeRate":-0.021348},{"month":6,"riseRate":0.6,"avgChangeRate":0.056003},{"month":7,"riseRate":1,"avgChangeRate":0.115584},{"month":8,"riseRate":0.25,"avgChangeRate":-0.063631},{"month":9,"riseRate":0.5,"avgChangeRate":-0.058511},{"month":10,"riseRate":0.4,"avgChangeRate":-0.00268},{"month":11,"riseRate":1,"avgChangeRate":0.145659},{"month":12,"riseRate":0.8,"avgChangeRate":0.186995}],"exchange":"NASDAQ","name":"SpringWorks Therapeutics, Inc.","nameEN":"SpringWorks Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SpringWorks Therapeutics, Inc.(SWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供SpringWorks Therapeutics, Inc.(SWTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"SpringWorks Therapeutics, Inc.,SWTX,SpringWorks Therapeutics, Inc.股票,SpringWorks Therapeutics, Inc.股票老虎,SpringWorks Therapeutics, Inc.股票老虎国际,SpringWorks Therapeutics, Inc.行情,SpringWorks Therapeutics, Inc.股票行情,SpringWorks Therapeutics, Inc.股价,SpringWorks Therapeutics, Inc.股市,SpringWorks Therapeutics, Inc.股票价格,SpringWorks Therapeutics, Inc.股票交易,SpringWorks Therapeutics, Inc.股票购买,SpringWorks Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SpringWorks Therapeutics, Inc.(SWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供SpringWorks Therapeutics, Inc.(SWTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}